Description
TIRZEPATIDE is a novel experimental peptide currently being studied for its potential dual agonist activity on GIP and GLP-1 receptors. This mechanism is being investigated for its effects on improving insulin sensitivity, enhancing glycemic control, and supporting healthy weight reduction. Laboratory studies are focused on understanding its role in metabolic regulation, obesity management, and type 2 diabetes research.
Specifications:
- Unit Size: 30 mg per vial
- Storage: Store in a cool, dry place away from direct light
- Ingredients: TIRZEPATIDE peptide (purity ≥ 98%), mannitol (as excipient)
Intended Use:
This product is intended strictly for laboratory research purposes only. It is not for human or veterinary consumption, and must not be used as a drug, food additive, cosmetic, or household item.
⚠️ Disclaimer:
TIRZEPATIDE is sold for in vitro research and educational use only. This compound has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease. Purchase is limited to qualified researchers and licensed institutions.
Terms of Sale:
By purchasing this product, you confirm that you are a qualified professional conducting lawful scientific research. ThriveWell Collective LLC and its affiliates are not liable for any misuse or mishandling of this material.




There are no reviews yet.